# OnCo record cg-oncology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/cg-oncology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "cg-oncology" ;
  schema:name "CG Oncology"@en ;
  schema:description "CG Oncology developed cretostimogene, the oncolytic virus for early bladder cancer, and is filing for approval in 2026."@en ;
  schema:url <https://onco.cc/companies/cg-oncology/>, <https://cgoncology.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://cgoncology.com> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/cretostimogene/> ;
  onco:trials <https://onco.cc/trials/nct06111235/>, <https://onco.cc/trials/nct06567743/> .